Pharmaceuticals · medium ·
Pharma R&D federated learning is outrunning its licensing shortage
Federated learning networks are emerging as a standard mechanism for pharmaceutical companies to collaboratively fine-tune foundation AI models. This approach allows for the secure leveraging of external AI advancements without compromising proprietary research data or intellectual property, driving a new era of secure, collaborative AI development in R&D.
Part of the Healthcare & Life Sciences Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.